-- 加拿大財政部週五表示,2月份的預算盈餘較上月下降,而2025年4月至2026年2月期間的赤字則有所擴大。該部門將於下週二發布春季經濟報告。 財政部在其最新的財政監測報告中指出,2月份的預算盈餘為57億加元,低於2025年2月的76億加元。 報告也指出,扣除精算淨損益前的預算盈餘為61億加元,而2024-2025財年同期為79億加元。財政部強調,扣除精算淨損益前的預算餘額旨在補充傳統的預算餘額,並透過隔離因政府退休金和其他員工未來福利計畫重估而產生的精算淨損益攤銷的影響,提高政府財務報告的透明度。 與2025年2月相比,財政收入下降了28億加元,降幅為5.5%,主要原因是企業所得稅收入減少以及返還給加拿大民眾的污染定價收入減少。財政監測報告指出,其他收入的增加部分抵消了這些下降。剔除精算淨虧損後的項目支出減少了11億加元,降幅為2.8%,原因是與向各省、地區和市政當局撥付主要款項的時間安排相關的支出減少,部分被向個人撥付主要款項和直接項目支出的增加所抵消。 2025年4月至2026年2月期間,政府預算赤字為255億加元,而2024-25財年同期赤字為193億加元。政府表示,財政收入增加了34億美元,增幅0.8%,這「主要反映了因應對美國關稅而採取的反制措施導致的進口關稅增加、個人和企業所得稅收入以及其他收入的增長」。 然而,2025/26年度的專案支出(不包括精算損失)增加了8.8%,這「主要反映了對個人和直接專案支出的重大轉移支付增加,部分被加拿大碳排放退稅計畫的逐步取消所抵消」。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.